Mosept-Oral
Cosmos Holdings Launches Mosept-Oral Antiseptic Spray Designed to be Effective Against Bacteria and Certain Viral Pathogens
April 08, 2021 10:05 ET | Cosmos Holdings Inc.
New proprietary formula for the symptomatic relief of pain and irritated sore throat Initial launch in 3,500 pharmacies in Greece with plans to expand to the UK, Germany, the Netherlands, France,...
Osteodome
Cosmos Holdings Launches Osteodome in EU
February 11, 2021 21:35 ET | Cosmos Holdings Inc.
New Proprietary Dietary Supplement Contributes to NormalBone and Cartilage Health and Joint Flexibility Osteodome Is Second Product to Be Marketed throughout the UKDuring First Quarter 2021 EU...
Bodyguard
Cosmos Holdings Launches New Proprietary Enhanced Dietary Supplement
January 11, 2021 09:30 ET | Cosmos Holdings Inc.
CHICAGO, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the company") (OTCQX: COSM), a vertically integrated international pharmaceutical company with a proprietary line of branded and...
Cosmos Logo.jpg
Cosmos Holdings Announces December 4th Virtual Bell Ringing to Open Trading on the OTCQX Best Market
December 04, 2020 12:23 ET | Cosmos Holdings Inc.
CHICAGO, Dec. 04, 2020 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the company") (OTCQX: COSM), a vertically integrated international pharmaceutical company with a proprietary line of branded and...
Cosmos Logo.jpg
Cosmos Holdings Begins Trading on the OTCQX® Best Market
November 25, 2020 09:46 ET | Cosmos Holdings Inc.
CHICAGO, Nov. 25, 2020 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the company") (OTCQX: COSM), a vertically integrated international pharmaceutical company with a proprietary line of branded and...
Cosmos Logo.jpg
Cosmos Holdings, Inc. Reports Record Third Quarter and Nine-Month Financial Results
November 17, 2020 09:17 ET | Cosmos Holdings Inc.
Revenue Increases 48%, Gross profit increased 210% to $2.39 million andEarnings Rise over Same 2019 PeriodGenerics and Nutraceuticals Lead Expansion in EuropeRobotic Automations Enhance Margins and...
Cosmos Logo.jpg
David Lowenstein Agrees to Join Cosmos Board of Directors
November 02, 2020 09:36 ET | Cosmos Holdings Inc.
Seasoned Entrepreneur Has Taken Several Companies from Start-Up to IPO and has served on the boards of several NASDAQ and TSXV companies Appointment Follows Recent Board Selection of Peter Goldstein,...
Cosmos Logo.jpg
Cosmos Holdings Engages PGS Ventures to Advise on Strategic Transactions to Accelerate Core Business Expansion
October 16, 2020 09:00 ET | Cosmos Holdings Inc.
CHICAGO, Oct. 16, 2020 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (the “Company") (OTCQB: COSM), an international pharmaceutical company, announced today that it has entered into an advisory...
Cosmos Logo.jpg
Cosmos Holdings, Inc. Announces Q2 2020 Financial and Operating Results
August 18, 2020 13:46 ET | Cosmos Holdings Inc.
CHICAGO, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (the “Company") (OTCQB: COSM), an international pharmaceutical company, announced consolidated financial results for the first six...
Cosmos Logo.jpg
Cosmos Holdings, Inc. Announces Year End 2019 & Q1 2020 Financial and Operating Results
May 20, 2020 08:00 ET | Cosmos Holdings Inc.
CHICAGO, May 20, 2020 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (the ‘’Company") (OTCQB: COSM), an international pharmaceutical company, announced consolidated financial results for the fiscal year...